Pertuzumab
| CAS No. | 380610-27-5 | Cat. No. | BCP18201 |
| Name | Pertuzumab | ||
| Synonyms | |||
| Formula | M. Wt | ||
| Description | Pertuzumab is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | HER2 | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.